Fentanyl Patch Recall
April 18, 2011, by Ronald V. Miller, Jr.
Fentanyl patches: Generic drugmaker Actavis issued a recall for 200,000 units of its Fentanyl Transdermal System 25mcg/h (called Fentanyl patches) because they exceeded dissolution specifications in stability testing.
There are a lot of lawsuits involving Fentanyl patches for other reasons but there is nothing to indicate this recall is a big deal.
